are at work f o r cellular antigens also. This confirms their im- Elimination of B cells was performed by incubation with goat antiserum to mouse Ig (Gibco, BCL 1039). The serum was absorbed with C3H mouse thymocytes until there was no more cytotoxicity against thymocytes. 15 x 1 O6 cells were incubated in 0.2 ml of antiserum 30 min in 37 "C, washed and incubated again with an equal volume of guinea pig complement absorbed with mouse liver powder.
in vitro. Spleen lymphocytes from normal and immunized mice of t h e inbred strains C 3 H and DBA/2 were incubated with vaccinia virus-infected a n d noninfected 5 1 Cr-labeled mastocytoma P-815-X2 cells a n d L-929 fibroblasts, which were used as targets., Cytotoxic lymphocytes could be isolated from t h e mice as early a s 2 days after infection with vaccinia virus. T h e highest cytotoxic effect was obtained with lymphocytes taken 6 days after infection. T h e degree of lysis we established an in vitro system t o show cytotoxic actions of spleen celb from vaccinia virus-infected mice against vaccinia-infected target cells. We investigated: (a) the kinetics of in vivo production of cytotoxic lymphocytes (CL), (b) the cell type of the effector cell, (c) the interactions between antibodies and CL, (d) the virus specificity and the target cell specificity of the in vitro reaction.
Materials and methods

Viruses and animals used
Vaccinia virus strain WR was propagated in Vero cells (Green African monkey kidney) cultivated in Eagle's medium supplemented with 100 IU/ml penicillin, 100pg/ml streptomycin and 10 %inactivated calf serum. Stock virus contained lo6 TCIDSO/ ml. Herpes simplex virus type I was grown in Vero cells; the stock virus was equilibrated to 1 O6 TCIDSO /ml. Titration of virus was performed in Vero cells using the microtiter system (Greiner, Nurtingen, No 220 ART) with eight wells for every logarithmic dilution step. Reading was performed according t o the method of Reed and Muench. Mice of the inbred strains C3H/TIF and DBA/2 (purchased from G.L. Bomholtgird, Ry Denmark) were used throughout the study.
Lymphoid cell suspensions
\
Lymphocytes were obtained from the mouse spleens at different times after injection of 1-2 ml 10' -1 O6 TCIDSO/ml of vaccinia virus, herpes simplex virus or Eagle's medium. Cell suspensions from spleens were obtained by the following procedure: spleens from five mice were aseptically removed, homogenized by hand with one gentle stroke in a IS ml glass homogenizer (Tenbroeck) containing I0 ml Eagle's medium supplemented with 10 % fetal calf serum, 1 % L-glutamin (200 mmoles), 1 76 50-fold concentrated amino acids (Microbiological Assoc., Bethesda, Md., N o 13-606), 100 IU/ml penicillin and 100 pg/ml streptomycin. The suspension was transferred t o a tube, underlayed with calf serum and incubated for 5 min at 4 "C to remove spleen debris and clumped cells. The supernatant was removed and underlayed again with serum and the cells were pelleted by centrifugation for 10 min with 250 x g at 4 "C. The supernatant containing smooth debris was discarded. The cells were resuspended and viability was tested by trypan blue exclusion. 
T cell elimination
Anti-@ serum from AKR mice was kindly provided by Dr.
Rollinghoff, Mainz. 
Anti-vaccinia serum
Hyperimmune serum was obtained from sensitized rabbits injected intracutaneously with 5 ml 1 O6 TCIDso/ml followed 6-10 weeks later by booster intravenous injections of the same dosage. Syngeneic hyperimmune serum was obtained from mice after three intraperitoneal injections of 2 ml 1 O6 TCIDso/ml given at two week intervals. The animals were bled one week after the last injection. Normal serum was obtained from noninfected animals. All sera were inactivated and stored at -70 "C.
Target cells
L-929 cells, kindly provided by Dr. Lehmann-Grube, Hamburg, were grown as monolayers in MEM containing 10 % FCS and 100 pg/ml of penicillin and streptomycin in Roux bottles. Mastocytoma P-8 15-X2 suspension cultures were grown in 10 cm Petri dishes containing Dulbecco's fortified Eagle's medium (Grand Island Biological Co.) with 10 % FCS and antibiotics, on a rocker platform (Bellco Glass Co, Vineland, N.Y.) in a humidified 8 % C02-atmosphere.
Infection of target cells
Monolayers of L-929 cells were trypsinized, suspended in fresh medium and plated in 0.1 ml volumes in sterile flat bottom microtest plates (Greiner, Nurtingen N o 220 ART)
t o reach a final concentration of 5 x 1 O4 cells/well. Five hours later the medium was removed and the cells were incubated with 0.2 ml virus suspension containing 5 x 1 O5 TCIDso/ 0.2 ml medium. Two hours later all the supernatants were discarded and fresh medium was added. Suspensions of mastocytoma P-815-X2 cells were infected by incubating the cells in a medium containing 10 TCIDSO of virus per mastocytoma cell under constant rocking. After 2 h the cells were washed and resuspended in fresh medium.
Five times 1 O6 infected o r noninfected mastocytoma cells were suspended in 0.2 ml medium and 100 yCi "Cr (sodiumchromat, Amersham, Buchler, Braunschweig N o CJSlP. spec. activity 100-200 mCi/mg Cr) was added. After 2 h incubation the cells were washed three times, resuspended to the required concentration and dispensed in microtiter wells t o a final concentration of 5 x 1 O4 cells/well. Infected or noninfected L-929 monolayers were labeled by adding 1 yCi Cr to each well. After 2 h incubation the monolayers were gently washed three times.
Cytotoxic assay
The assay is a modification of the technique described by Brunner et al. [21] . Following incubation for 4-20 h the microplates were centrifuged at 1000 rpm for 5 min. 0.1 ml of cell-free supernatant was gently removed and the residual 0.1 ml volume was harvested by vigorous pipetting t o suspend the adherent cells. The volumes containing cell-free supernatant or supernatant with cells were counted and "Cr release in the whole supernatant was calculated using the formula:
counts in supernatants -background counts counts in whole supernatant + cells -background counts
The percentage of specific cytolysis of infected target cells was calculated by subtracting from the percentage Cr released in the presence of immune spleen cells that percentage of "Cr released by the same number of cells from noninfected animals.
Results
Infection conditions
The infection of mastocytoma and L-929 cells with 10 TCIDSO/ cell vaccinia virus induces cytolysis. In the L cells, which were grown as monolayers, the infection led t o the appearance of round cells after 4 h, followed by aggregation of cells after (Table I ) . A significant increase of infectivity titer was observed after 30 h. The mastocytoma P-8 1 5 x 2 suspension cultures had a similar spontaneous "Cr release after infection ( Table 5 ). The infected cells could be used 2 h after infection, but often higher percentage of specific cell cytolysis by immune lymphocytes could be obtained with cells infected for a longer period. Twelve hour infected cells were usually utilized as targets.
The development of early virus-specific antigens after vaccinia virus infection has already been described [22] . We could observe specific surface immunofluorescence in infected L-929 or mastocytoma P-815-X2 cells, beginning 2 h after infection, using human anti-vaccinia hyperimmune sera. Fluorescence was more pronounced and visible o n a higher percentage of cells in later stages of infection, reaching a percentage of 70-80 % of labeled cells.
Effects of sensitized lymphocytes o n infected target cells
C3H/TIF mice were infected intraperitoneally with 2 ml Eagle's medium containing 1 O6 TCIDSo/ml vaccinia virus. Control animals received virus-free medium. Six days later the mice were sacrificed, the spleens of 5 mice from each group were pooled and spleen cell suspensions were prepared. The cells were incubated for 20 h with "Cr-labeled, infected and noninfected L-929 cells and the "Cr release was calculated. Incubation of spleen cells from sensitized mice with vaccinia virusinfected target cells led t o significant chromium release, while noninfected targets remained unaffected. Control spleen cells did not relevantly affect the target cells (Table 1) . The spleen cells were harvested 6 days later and incubated for 20 h with either vaccinia virus-infected or noninfected L-929 cells. Only cells from vaccinia virus-sensitized animals were able t o lyse the infected target cells in significant amounts (Table 2) .
3.4.
Time course of development of cytotoxic lymphocytes C3H mice were injected with 2 ml containing 1 x I Os'4 TCIDSo/ ml vaccinia virus. Beginning 2 days after injection, groups of 5 infected or mock-infected animals were killed and the cytotoxicity test was performed. Occurrence of CL could be observed after 2 days, reaching a maximum after one week and declining in the second week after infection (Fig. I ) . At day 12 only weak cytotoxicity remained. 
In vitro kinetics of target cell lysis
The following experiment was performed using a constant ratio (100: 1) of lymphocytes t o target cells. Spleen lymphocytes were obtained from 6-day infected C3H mice and control animals. While the total amount of lymphocytes was kept constant, different percentages of lymphocytes from sensitized animals were mixed with normal lymphocytes and incubated with the target cells. At intervals of 5 h the reactions were stopped and the "Cr release was tested. Specific lysis could be observed as early as at 5 h incubation. T h e increase of Cr release takes a nearly linear course when correlated with time. The time-dependent increase of release is consistent with the percentage of sensitized lymphocytes in the reaction (Fig. 2 ).
Cr
The ratio of 100 lymphocytes to 1 target cell seems t o be the optimal concentration of effector cells t o targets. Further additions of semitiled lymphocytes to a constant number of target cells exceeding the rat10 100: 1 d o not lead t o a n increase of chromium release (Fig. 3) . In some experiments a slight dccrease of Cr release could be observed a t ratios over 100: 1.
Effect of anti-vaccinia antibodies on vaccinia virusinfected target cell lysis
Incubation of infected target cells with human anti-vaccinia antibody together with agarose-absorbed guinea pig complement for 2 0 h resulted in only slight cytolysis. Antibody or Eur. J. Immunol.
-. 
Characterization of the effector cell
In the in vitro system virus-specific cytolysis of vaccinia-infected target cells could be obtained with spleen cells and peritoneal exudate cells from vaccinia virus-infected animals, while normal cells had no effect. Immune spleen lymphocytes were incubated with anti-mouse lg for 30 min, washed and reincubated with absorbed guinea pig complement. This procedure led t o a 46 % killing of Ficoll-Isopaque purified cells. Spleen cell cytotoxicity was not found t o be reduced significantly. Likewise the elimination of Ig-bearing cells by adherent properties in a nylon wool column had no effect on the cytolytic activity of the effluent cell fraction.
A glass bead column was used t o eliminate macrophages. The removal of macrophages had no effect on target cell lysis. These results suggest that cells with adherent properties. d) Significant inhibition of 51Cr release by immune mouse (P < 0.001), rabbit ( P < 0.001) and human (P < 0.001) sera.
cytophilic antibodies, are not responsible for vaccinia virusspecific target cell killing.
After incubation of cells with anti@ serum and then with complement, 3 2 70 of cells were dead, calculated by trypan blue exclusion. The treatment of spleen cell or peritoneal exudate cells with anti-@ serum and complement resulted in significant reduction o f target cell killing. Treatment with anti@ serum without complement is not followed by reduction of " Cr release (Table 4) . c) Significant reduction (P < 0.001) of target cell lysis after pretreatment of lymphocytes with anti-@ serum and complement.
Effect of target cell specificity on virus-specific lymphocyte cytotoxicity
Sensitized lymphocytes from C3H mice were able t o kill vaccinia-infected L-929 cells; the noninfected cells usually were not affected. When lymphocytes from DBA/2 mice were used, the vaccinia-infected L-929 cells were not killed b y the normal or the immune lymphocytes. Likewise the immune lymphocytes from C3H mice n o longer had cytolytic activities on vaccinia-infected mastocytoma P-8 I 5 x 2 target cells. Immune cells from C5 7BL/6J mice had no significant effects on vaccinia infected L-929 cells or vaccinia-infected mastocytoma P-815-X2 cells (unpublished data). When a cross-reaction was performed using cells from normal and infected C3H and DBA/2 mice against infected and noninfected L-929 and mastocytoma P-8 15x2 target cells. C3H lymphocytes only lysed infected L-929 cells, while DBA/2 lymphocytes only lysed the infected mastocytoma P-8 1 5 x 2 cells (Table 5) .
Since C3H mice and L-929 cells share t h e same H-2k antigen and DBA/2 mice have the same H-2d antigen as d o mastocytoma P-815-X2 cells, it could be concluded that vaccinia virus-specific lymphocyte cytotoxicity for target cells is dependent on transplantation antigen compatibilities. It has been demonstrated that antibodies can be raised which are directed only against virus-specific surface antigens or viral structural antigens of vaccinia virus [26] . It has, however, t o be elucidated if antibodies, which are directed solely against viral structural antigens, are able t o block the action of CL. It seems obvious that CL play a role in host resistance t o viral infections, but the importance of this effect remains t o be defined. It has been shown recently that in an acute infection with sindbis virus, CL have no effect on virus clearance [ 141.
Virus clearance could be attributed t o the action of macrophages which may act in an activated state or be "armed" by immune T cells [30] with or without the help of antibodies or lymphocytes [3 I] . In the vaccinia system we could show that clearance of virus in virro is possible without the cytolysis by CL (manuscript in preparation).
In our experimental system CL from C3H mice could only kill infected L cells but not infected or noninfected mastocytoma P815-X2 cells. The action of CL from DBA/2 mice was also specific; they had cytolytic effects only on infected mastocytoma cells. In a recent investigation it has been observed [ 151 that in the lymphocytic choriomeningitis system, target cell lysis was restricted t o syngeneic or semiallogeneic systems. Since LCM is a budding virus it seems possible that this effect was caused by this type of virus maturation, followed by alteration of H-2 antigen concentration o n the surface of infected cells [32] . The H-2 antigen-specific restriction of cytolysis in the vaccinia system suggests that this restriction is caused by a more general phenomenon. This is supported by the data of Shearer [33] , showing cell-mediated cytotoxicity to trinitrophenyl-modified lymphocytes in a syngeneic system. In another pox virus system using ectromelia virus, different CL activities on various-infected cells were interpreted as different expressions of viral surface antigens on the target cells [ 131. However, if one correlates the results of specific target cell destruction with H-2 antigen compatibility, there is a decrease of cytolytic effects consistent with increasing antigenic heterogenicity. Secondly, the infected mastocytoma cell was, in our system, just as lysable as the L cells under the prerequisite that the syngeneic cytolytic effector cell was used. Other investigators communicated virus-specific lysis of heterologous infected target cells [5, 10, 111 . For these systems the T cell specificity of the reaction has t o be elucidated t o exclude antibody-dependent activities [34-371. On the other hand, one could also suppose that high concentrations of virus-specific antigens on cell surfaces can be recognized in spite of foreign transplantation antigen structures.
